Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhLactoferrin for chronic inflammation in the elderly
NCT02968992Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2017
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of lactoferrin in chronic inflammation, sponsored by Johns Hopkins University. Started Aug 2017; status: completed.
02
Drugs
lactoferrin
03
Conditions
chronic inflammation
Beyond the preview
Go deeper on NCT02968992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968992.